A Look Ahead: VolitionRX's Earnings Forecast

Comments
Loading...

VolitionRX VNRX is preparing to release its quarterly earnings on Monday, 2025-03-31. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect VolitionRX to report an earnings per share (EPS) of $-0.05.

The market awaits VolitionRX's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

It's important for new investors to understand that guidance can be a significant driver of stock prices.

Historical Earnings Performance

The company's EPS missed by $0.00 in the last quarter, leading to a 5.56% drop in the share price on the following day.

Here's a look at VolitionRX's past performance and the resulting price change:

Quarter Q3 2024 Q2 2024 Q1 2024 Q4 2023
EPS Estimate -0.07 -0.09 -0.11 -0.11
EPS Actual -0.07 -0.08 -0.10 -0.11
Price Change % -6.0% 3.0% -15.0% 4.0%

eps graph

Performance of VolitionRX Shares

Shares of VolitionRX were trading at $0.528 as of March 27. Over the last 52-week period, shares are down 31.3%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for VolitionRX visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

VNRX Logo
VNRXVolitionRX Ltd
$0.4680-2.50%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
23.15
Growth
86.52
Quality
-
Value
7.81
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: